The Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS): Development and assessment of reliability

Andreas Charidimou1, Anne Schmitt2, Duncan Wilson3

  • 1UCL Stroke Research Centre, UCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK; Hemorrhagic Stroke Research Group, Harvard Medical School, Massachusetts General Hospital, Boston, USA.

Insights

A new tool, the Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS), reliably classifies spontaneous intracerebral haemorrhage (ICH) locations. This aids in understanding ICH causes, risk factors, and prognosis.

Area of Science:

  • Neurology
  • Radiology
  • Medical Informatics

Background:

  • Spontaneous intracerebral haemorrhage (ICH) prognosis is influenced by anatomical location (lobar vs. non-lobar).
  • Accurate classification of ICH location is crucial for research and clinical applications.

Purpose of the Study:

  • To systematically develop and validate a reliable instrument for classifying the anatomical location of spontaneous ICH.
  • Introduce the Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS).

Main Methods:

  • A two-stage iterative Delphi-style method was employed for instrument development.
  • The CHARTS instrument was validated on CT and MRI scans of 227 acute spontaneous symptomatic ICH patients.
  • Interrater and intrarater reliability were assessed using kappa statistics.

Main Results:

  • The CHARTS instrument demonstrated excellent interrater reliability (kappa > 0.80) for classifying lobar, deep, infratentorial, and uncertain ICH locations.
  • Substantial to almost perfect intrarater reliability was observed (kappa = 0.83 and 0.95).
  • Reliability remained consistent across individual cerebral lobar regions.

Conclusions:

  • The CHARTS instrument provides a reliable and comprehensive method for mapping spontaneous ICH anatomical locations.
  • CHARTS can facilitate research into ICH causes, risk factors, and prognosis.
  • The instrument may aid in patient stratification for clinical trials.
Abstract

Related Concept Videos